OBJECTIVE: Chronic manganese (Mn) intoxication induces syndromes resembling Parkinson disease. The clinical intervention has largely been unsuccessful. We report a 17-year follow-up study of effective treatment of occupational Mn parkinsonism with sodium para-aminosalicylic acid (PAS). METHODS: The patient, female and aged 50 at the time of treatment, was exposed to airborne Mn for 21 years (1963-1984). The patient had palpitations, hand tremor, lower limb myalgia, hypermyotonia, and a distinct festinating gait. She received 6 g PAS per day through an intravenous drip infusion for 4 days and rested for 3 days as one therapeutic course. Fifteen such courses were carried out between March and June 1987. RESULTS: At the end of PAS treatment, her symptoms were significantly alleviated, and handwriting recovered to normal. Recent follow-up examination at age 67 years (in 2004) showed a general normal presentation in clinical, neurologic, brain magnetic resonance imaging, and handwriting examinations with a minor yet passable gait. CONCLUSIONS: This case study suggests that PAS appears to be an effective drug for treatment of severe chronic Mn poisoning with a promising prognosis.
OBJECTIVE: Chronic manganese (Mn) intoxication induces syndromes resembling Parkinson disease. The clinical intervention has largely been unsuccessful. We report a 17-year follow-up study of effective treatment of occupational Mn parkinsonism with sodium para-aminosalicylic acid (PAS). METHODS: The patient, female and aged 50 at the time of treatment, was exposed to airborne Mn for 21 years (1963-1984). The patient had palpitations, hand tremor, lower limb myalgia, hypermyotonia, and a distinct festinating gait. She received 6 g PAS per day through an intravenous drip infusion for 4 days and rested for 3 days as one therapeutic course. Fifteen such courses were carried out between March and June 1987. RESULTS: At the end of PAS treatment, her symptoms were significantly alleviated, and handwriting recovered to normal. Recent follow-up examination at age 67 years (in 2004) showed a general normal presentation in clinical, neurologic, brain magnetic resonance imaging, and handwriting examinations with a minor yet passable gait. CONCLUSIONS: This case study suggests that PAS appears to be an effective drug for treatment of severe chronic Mn poisoning with a promising prognosis.
Authors: Jeffrey D Rothstein; Sarjubhai Patel; Melissa R Regan; Christine Haenggeli; Yanhua H Huang; Dwight E Bergles; Lin Jin; Margaret Dykes Hoberg; Svetlana Vidensky; Dorothy S Chung; Shuy Vang Toan; Lucie I Bruijn; Zao-Zhong Su; Pankaj Gupta; Paul B Fisher Journal: Nature Date: 2005-01-06 Impact factor: 49.962
Authors: Y Kim; J-M Kim; J-W Kim; C-I Yoo; C R Lee; J H Lee; H K Kim; S O Yang; H K Chung; D S Lee; B Jeon Journal: Mov Disord Date: 2002-05 Impact factor: 10.338
Authors: Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens Journal: Neuromolecular Med Date: 2009 Impact factor: 3.843
Authors: Aditya N Bade; Biyun Zhou; JoEllyn McMillan; Prabagaran Narayanasamy; Ram Veerubhotla; Howard E Gendelman; Michael D Boska; Yutong Liu Journal: J Neurosci Methods Date: 2015-05-22 Impact factor: 2.390
Authors: Stefanie L O'Neal; Lan Hong; Sherleen Fu; Wendy Jiang; Alexander Jones; Linda H Nie; Wei Zheng Journal: Toxicol Lett Date: 2014-06-12 Impact factor: 4.372
Authors: Dallas M Cowan; Wei Zheng; Yan Zou; Xiujuan Shi; Jian Chen; Frank S Rosenthal; Qiyuan Fan Journal: Neurotoxicology Date: 2009-02-20 Impact factor: 4.294